230 related articles for article (PubMed ID: 22619508)
21. Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery.
Slastnikova TA; Rosenkranz AA; Gulak PV; Schiffelers RM; Lupanova TN; Khramtsov YV; Zalutsky MR; Sobolev AS
Int J Nanomedicine; 2012; 7():467-82. PubMed ID: 22346349
[TBL] [Abstract][Full Text] [Related]
22. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
[TBL] [Abstract][Full Text] [Related]
23. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
Chen YC; Chang WH; Wang SJ; Hsieh WY
J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
[TBL] [Abstract][Full Text] [Related]
24. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309
[TBL] [Abstract][Full Text] [Related]
25. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.
Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN
J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683
[TBL] [Abstract][Full Text] [Related]
26. Alpha-melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targeting.
Chen J; Cheng Z; Miao Y; Jurisson SS; Quinn TP
Cancer; 2002 Feb; 94(4 Suppl):1196-201. PubMed ID: 11877745
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.
Damiani V; Falvo E; Fracasso G; Federici L; Pitea M; De Laurenzi V; Sala G; Ceci P
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718812
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of dual-functional targeting probes for cancer theranostics based on iron oxide nanoparticles coated by centipede-like polymer connected with pH-responsive anticancer drug.
Zhao H; Li Z; Yang B; Wang J; Li Y
J Biomater Sci Polym Ed; 2015; 26(16):1178-89. PubMed ID: 26249213
[TBL] [Abstract][Full Text] [Related]
29. The pharmacological properties of 3-arm or 4-arm DOTA constructs for conjugation to α-melanocyte-stimulating hormone analogues for melanoma imaging.
Kobayashi M; Kato T; Washiyama K; Ihara M; Mizutani A; Nishi K; Flores LG; Nishii R; Kawai K
PLoS One; 2019; 14(3):e0213397. PubMed ID: 30901323
[TBL] [Abstract][Full Text] [Related]
30. Investigation of adhesive interactions in the specific targeting of Triptorelin-conjugated PEG-coated magnetite nanoparticles to breast cancer cells.
Hu J; Youssefian S; Obayemi J; Malatesta K; Rahbar N; Soboyejo W
Acta Biomater; 2018 Apr; 71():363-378. PubMed ID: 29458110
[TBL] [Abstract][Full Text] [Related]
31. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
32. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
33. A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.
Froidevaux S; Calame-Christe M; Tanner H; Sumanovski L; Eberle AN
J Nucl Med; 2002 Dec; 43(12):1699-706. PubMed ID: 12468522
[TBL] [Abstract][Full Text] [Related]
34. Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.
Guo H; Yang J; Gallazzi F; Prossnitz ER; Sklar LA; Miao Y
Bioconjug Chem; 2009 Nov; 20(11):2162-8. PubMed ID: 19817405
[TBL] [Abstract][Full Text] [Related]
35. Antibody-drug conjugates: targeting melanoma with cisplatin encapsulated in protein-cage nanoparticles based on human ferritin.
Falvo E; Tremante E; Fraioli R; Leonetti C; Zamparelli C; Boffi A; Morea V; Ceci P; Giacomini P
Nanoscale; 2013 Dec; 5(24):12278-85. PubMed ID: 24150593
[TBL] [Abstract][Full Text] [Related]
36. Targeted melanoma radiotherapy using ultrasmall
Zhang X; Chen F; Turker MZ; Ma K; Zanzonico P; Gallazzi F; Shah MA; Prater AR; Wiesner U; Bradbury MS; McDevitt MR; Quinn TP
Biomaterials; 2020 May; 241():119858. PubMed ID: 32120314
[TBL] [Abstract][Full Text] [Related]
37. PEG-conjugated highly dispersive multifunctional magnetic multi-walled carbon nanotubes for cellular imaging.
Khandare JJ; Jalota-Badhwar A; Satavalekar SD; Bhansali SG; Aher ND; Kharas F; Banerjee SS
Nanoscale; 2012 Feb; 4(3):837-44. PubMed ID: 22170574
[TBL] [Abstract][Full Text] [Related]
38. Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy.
Ma Z; Hu P; Guo C; Wang D; Zhang X; Chen M; Wang Q; Sun M; Zeng P; Lu F; Sun L; She L; Zhang H; Yao J; Yang F
Int J Nanomedicine; 2019; 14():5527-5540. PubMed ID: 31413561
[No Abstract] [Full Text] [Related]
39. RGDS-functionalized polyethylene glycol hydrogel-coated magnetic iron oxide nanoparticles enhance specific intracellular uptake by HeLa cells.
Nazli C; Ergenc TI; Yar Y; Acar HY; Kizilel S
Int J Nanomedicine; 2012; 7():1903-20. PubMed ID: 22619531
[TBL] [Abstract][Full Text] [Related]
40. Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties.
Raposinho PD; Xavier C; Correia JD; Falcão S; Gomes P; Santos I
J Biol Inorg Chem; 2008 Mar; 13(3):449-59. PubMed ID: 18183429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
